ARCHIVES

Human Embryo Panel Defines Acceptable Research For Funding

This article is from The Cancer Letter archive.

Vol. 20 No. 37 | September 30, 1994

Download PDF Visit The Full Archive

Related Articles

Weekly Paclitaxel Better Than Every Three Weeks

June 25, 2004

NCI Cooperative Groups Recognized By ASCO For 50+ Years Of Clinical Trials.

June 1, 2007

Guest Editorial “Gizmo Idolatry” and Marketing Da Vinci’s Radical Robot

September 26, 2014

GSK’s Pazopanib Benefits Similar to Sunitinib; Sponsor Points to More Favorable Safety Profile

August 30, 2013

Zaltrap Shows Improvement in Survival In Stage IV Metastatic Colorectal Cancer

July 29, 2011

ORI Must Release Documents In Fisher Case, Judge Rules

September 8, 1995